BlockBeats 消息，3 月 21 日，YZi Labs 宣布 Jane He 担任普通合伙人，将领导其生物技术投资，同时为 YZi Labs 更广泛的 AI 和 Web3 战略做出贡献。
YZi Labs 表示，从斯坦福大学 GSB 毕业后，Jane 在生物技术和医疗技术方面有着良好的记录，积极寻求人工智能和生物技术交叉领域的颠覆性机会。她的专长涵盖癌症治疗、基因编辑、代谢治疗和 AI 驱动的生物技术解决方案，为投资带来了富有远见的方法。生物技术处于科学创新的前沿，并将改变更广泛的人类体验——从挽救生命的治疗到 AI 驱动的医学突破。Jane 的任命反映了 YZi Labs 对支持这一变革性行业和推动其向前发展的创始人的坚定承诺。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.